He Yan, Hu Zhi-Feng, Li Ping, Xiao Cheng, Chen Yu-Wu, Li Ke-Ming, Guo Jing-Zhen, Pan Lin, Xiong Jia-Peng
The China-Japan Friendship Hospital, Beijing 100029, China.
Zhongguo Zhong Yao Za Zhi. 2008 Apr;33(8):915-9.
To study the effect of SSd on lipid peroxidation during experimental hepatic fibrosis progression.
The experimental models of hepatic fibrosis were induced by intraperitoneal injection of dimethylnitrosamine (DMN) on rats. SSd was administered by intraperitoneal injection for 4 weeks. Serum was analyzed for alanine and aspartate aminotransferase (ALT and AST), hyaluronic acid (HA), laminin (LN), collagen IV (IV-C), malonaldehyde (MDA) and superoxide dismutase (SOD) activities. Liver samples were measured for MDA contents and SOD activities in normal group, model group and SSd group.
SSd significantly decreased ALT and AST activities and lowered HA, LN and IV-C contents. It enhanced SOD activities in liver, while reduced MDA contents both in serum and liver.
SSd has obvious effects of protecting hepatocytes and resisting hepatic fibrosis, and the mechanism may be associated with its anti-lipid peroxidation effect.
研究丹参滴丸(SSd)在实验性肝纤维化进展过程中对脂质过氧化的影响。
通过腹腔注射二甲基亚硝胺(DMN)诱导大鼠肝纤维化实验模型。腹腔注射SSd 4周。分析血清中的丙氨酸和天冬氨酸转氨酶(ALT和AST)、透明质酸(HA)、层粘连蛋白(LN)、IV型胶原(IV-C)、丙二醛(MDA)和超氧化物歧化酶(SOD)活性。测定正常组、模型组和SSd组肝脏样本中的MDA含量和SOD活性。
SSd显著降低ALT和AST活性,降低HA、LN和IV-C含量。它增强肝脏中的SOD活性,同时降低血清和肝脏中的MDA含量。
SSd具有明显的保护肝细胞和抗肝纤维化作用,其机制可能与其抗脂质过氧化作用有关。